Skip to Main Content

Paper Details

Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers.
Clin Cancer Res
3
2023
Author NameAffiliation
Yasmeen Q RizviUniversity of Texas MD Anderson Cancer Center
Funda Meric-BernstamUniversity of Texas MD Anderson Cancer Center
Funda Meric-BernstamUniversity of Texas MD Anderson Cancer Center
  • 1 - 3

Datasets

Release 1.2